Adstiladrin: Uses, Dosage, Side Effects & Warnings - Drugs.com
Dec 9, 2024 · Adstiladrin is a prescription gene therapy used for the treatment of a certain type of bladder cancer. Adstiladrin contains nadofaragene firadenovec-vncg, a non-replicating …
Bladder Cancer Treatment Options
ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non …
First Bladder Cancer Patient Dosed with Commercially Available ...
Sep 12, 2023 · ADSTILADRIN ® (nadofaragene firadenovec-vncg) is the first and only FDA-approved intravesical gene therapy for the treatment of adult patients with high-risk Bacillus …
A Plain Language Summary of Nadofaragene Firadenovec Use for Bladder …
Nov 26, 2025 · It just uses the bladder cancer cells as a temporary factory to produce interferon where it's locally needed to treat those and target those cancer cells. So, nadofaragene …
Adstiladrin (Nadofaragene Firadenovec-Vncg) for bladder cancer
Adstiladrin is also called nadofaragene firadenovec-vncg. Adstiladrin is a gene therapy that uses a non-replicating adenoviral vector (a modified virus that cannot multiply) to deliver a gene to …
ADSTILADRIN® is indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in …
Real-World Evidence - ADSTILADRIN® (nadofaragene firadenovec …
ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non …
FDA Approval Summary: Nadofaragene Firadenovec-vncg for …
Apr 1, 2025 · Abstract On December 16, 2022, the FDA approved the adenoviral vector-based gene therapy nadofaragene firadenovec-vncg (brand name Adstiladrin) for the treatment of …
Nadofaragene firadenovec - Wikipedia
Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. [1][3][4] It is a non-replicating (cannot multiply in human cells) …
Adstiladrin for Bladder Cancer: Treatment & Benefits
Adstiladrin (nadofaragene firadenovec-vncg) is an FDA-approved gene therapy designed for high-risk BCG-unresponsive NMIBC. It represents a groundbreaking advancement in the treatment …